Mechanism of Action.
Mechano growth factor (MGF) is a splice variant of IGF-1, specifically the Ec isoform expressed in response to mechanical loading and muscle damage. Unlike standard IGF-1 (which primarily drives differentiation), MGF preferentially activates quiescent satellite cells (muscle stem cells), initiating proliferation and migration to damaged muscle fibers. This satellite cell activation is the critical first step in muscle repair and hypertrophy. PEGylation (attachment of polyethylene glycol chains) extends the otherwise very short half-life of native MGF from minutes to several hours, improving its research utility. MGF signals through the IGF-1 receptor but with different downstream emphasis: it activates ERK1/2 more potently than Akt, favoring proliferative over differentiation signaling in satellite cells.
Research Summary.
The discovery of MGF by Goldspink and colleagues established that mechanical loading produces a distinct IGF-1 splice variant that initiates muscle repair. Research shows MGF expression increases rapidly after exercise-induced muscle damage, preceding the expression of standard IGF-1 isoforms. In animal studies, MGF injection into muscle increased satellite cell activation and muscle fiber hypertrophy. The PEGylated form has been developed to address the impractically short half-life of native MGF. Studies in aged animals showed that MGF administration could partially restore the satellite cell response that declines with aging. However, the research base is smaller than for IGF-1 LR3, and most data comes from preclinical models. No human clinical trials have been conducted with PEG-MGF.
Side Effects & Safety.
PEG-MGF safety data is limited to preclinical studies. Theoretical concerns include potential effects on cell proliferation in non-muscle tissues, the immunogenic potential of PEGylated peptides (anti-PEG antibodies can develop with repeated dosing), and injection site reactions. As a growth factor, the same theoretical oncogenic concerns that apply to IGF-1 family compounds are relevant. The limited research base means comprehensive safety profiling has not been performed.
Legal Status & Access.
PEG-MGF is classified as a research compound. It is not FDA-approved and is prohibited by WADA in competitive athletics. Available from research peptide suppliers for laboratory investigation.